IR refers to the reduced ability of insulin target tissues to respond to insulin signaling, promoting compensatory hyperinsulinemia, which is closely associated with MetS and related disorders such as obesity, NAFLD, and hypertension [6]. This evidence concerns the gene INS and hypertensive disorder.